Skip to content
10-Q

Quarterly Report

GENELINK INC

0001144204-12-045061

← back to feed
Filed
Aug 14, 2012 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2012 · Aug 14, 2012 205.95M sh
Stockholders Equity Q2 2012 · Jun 30, 2012 −$2.29M
Stockholders Equity Q2 2012 · Dec 31, 2011 −$1.48M
Current Liabilities Q2 2012 · Jun 30, 2012 $2.12M
Current Liabilities Q2 2012 · Dec 31, 2011 $2.3M
Total Liabilities Q2 2012 · Jun 30, 2012 $4.42M
Total Liabilities Q2 2012 · Dec 31, 2011 $4.26M
Current Assets Q2 2012 · Jun 30, 2012 $1.07M
Current Assets Q2 2012 · Dec 31, 2011 $1.86M
Total Assets Q2 2012 · Jun 30, 2012 $2.12M
Total Assets Q2 2012 · Dec 31, 2011 $2.78M
Capex Q2 2012 · Jun 30, 2011 $2.74K
Operating Cash Flow Q2 2012 · Jun 30, 2011 −$1.08M
Cash And Equivalents Q2 2012 · Jun 30, 2011 $347.93K
Cash And Equivalents Q2 2012 · Dec 31, 2010 $429.3K
Sga Expense restated Q2 2012 · Jun 30, 2011 $1.58M
Sga Expense restated Q2 2012 · Jun 30, 2011 $2.96M
Rd Expense Q2 2012 · Jun 30, 2011 $7.59K
Rd Expense Q2 2012 · Jun 30, 2011 $16.61K
Net Income restated Q2 2012 · Jun 30, 2011 −$825.3K
Net Income restated Q2 2012 · Jun 30, 2011 −$1.42M
Operating Income restated Q2 2012 · Jun 30, 2011 −$758.47K
Operating Income restated Q2 2012 · Jun 30, 2011 −$1.28M
Gross Profit Q2 2012 · Jun 30, 2011 $867.74K
Gross Profit Q2 2012 · Jun 30, 2011 $1.77M
Cost Of Revenue Q2 2012 · Jun 30, 2011 $465.19K
Cost Of Revenue Q2 2012 · Jun 30, 2011 $965.6K